Thus, under the assumption that DH CCB initiators and ACE inhibitor or ARB initiators share similar trajectories in hypertension progression that would warrant the use of loop diuretics, our use of negative controls cannot fully explain the aSR among DH CCB users and further suggests the presence of a prescribing cascade in this population. This evidence concerns the gene ACE and hypertensive disorder.